Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding FCF Yield

The Free Cash Flow Yield of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Oct 18, 2026 is 7.51 %. In the previous year, Free Cash Flow Yield was 7.11 % — a change of 5.60% (higher).

FCF Yield

7.51 %

YoY

5.60%

Last updated:

Free Cash Flow Yield of Tibet Rhodiola Pharmaceutical Holding is 2025 7.51 % . Free Cash Flow Yield of Tibet Rhodiola Pharmaceutical Holding was 2024 7.11 % . It decreases by 5.60% higher compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
1.98 CNY
Jan 1, 2019
3.27 CNY
Jan 1, 2020
1.54 CNY
Jan 1, 2021
-0.44 CNY
Jan 1, 2022
5.47 CNY
Jan 1, 2023
7.88 CNY
Jan 1, 2024
7.11 CNY
Jan 1, 2025
7.51 CNY
The Tibet Rhodiola Pharmaceutical Holding FCF Yield history
YEARFCF YieldYoY
7.51 %+5.60%
7.11 %-9.74%
7.88 %+44.20%
5.47 %-1,345.45%
-0.44 %-128.54%
1.54 %-53.05%
3.27 %+65.73%
1.98 %-151.47%
-3.84 %-314.71%
1.79 %+95.16%
0.92 %-172.80%
-1.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co, listed on the Shanghai Stock Exchange under ticker 600211.SS, operates as a pharmaceutical company based in Lhasa, China. The company's ISIN is CNE000000ZW7. Founded through an IPO on July 21, 1999, it specializes in the manufacture and wholesale of pharmaceutical products. Its headquarters are located in Lhasa, Xizang, and it employs 615 full-time staff. The firm distributes proprietary drug products and processes pharmaceuticals, conducting business primarily across South China, North China, East China, Central China, and overseas markets. The company's website is http://www.xzyy.cn. It does not provide details on specific products, acquisitions, or financial figures beyond the IPO date and employee count. The company focuses on pharmaceutical manufacturing and distribution within its operational regions, with no additional information provided on its product lines or market share. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Free Cash Flow Yield of Tibet Rhodiola Pharmaceutical Holding is 7.51 % in 2025.

Free Cash Flow Yield of Tibet Rhodiola Pharmaceutical Holding changed from 7.11 % to 7.51 %, representing a 5.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Tibet Rhodiola Pharmaceutical Holding with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Tibet Rhodiola Pharmaceutical Holding

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding